Literature DB >> 11500942

Characterization of the upstream mouse Cbfa1/Runx2 promoter.

Z S Xiao1, S G Liu, T K Hinson, L D Quarles.   

Abstract

Cbfa1 (or Runx2/AML-3/PEPB2alpha) is a transcriptional activator of osteoblastic differentiation. To investigate the regulation of Cbfa1 expression, we isolated and characterized a portion of the 5'-flanking region of the Cbfa1 gene containing its "bone-related" or P1 promoter and exon 1. We identified additional coding sequence in exon 1 and splice donor sites that potentially give rise to a novel Cbfa1 isoform containing an 18 amino acid insert. In addition, primer extension mapping identified in the Cbfa1 promoter a minor mRNA start site located approximately 0.8 kb 5' upstream of the ATG encoding the MASN/p57 isoform and approximately 0.4 kb upstream of the previously reported start site. A luciferase reporter construct containing 1.4 kb of the mouse Cbfa1 promoter was analyzed in Ros 17/2.8 and MC3T3-E1 osteoblast cell lines that express high levels of Cbfa1 transcripts. The activity of this construct was also examined in non-osteoblastic Cos-7 and NIH3T3 cells that do not express Cbfa1 and mesenchymal-derived cell lines, including CH3T101/2, C2C12, and L929 cells, that express low levels of mature Cbfa1 transcripts. The 1.4 kb 5' flanking sequence of the Cbfa1 gene directed high levels of transcriptional activity in Ros 17/2.8 and MC3T3-E1 osteoblasts compared to non-osteoblasts Cos-7 cells, but this construct also exhibited high levels of expression in C310T1/2, L929, and C2C12 cells as well as NIH3T3 cells. In addition, Cbfa1 mRNA expression, but not the activity of the Cbfa1 promoter, was upregulated in a dose-dependent manner in pluripotent mesenchymal C2C12 by bone morphogenetic protein-2 (BMP-2). These data indicate that Cbfa1 is expressed in osteogenic as well as non-osteogenic cells and that the regulation of Cbfa1 expression is complex, possibly involving both transcriptional and post-transcriptional mechanisms. Additional studies are needed to further characterize important regulatory elements and to identify additional regions of the promoter and/or post-transcriptional events responsible for the cell-type restricted regulation of Cbfa1 expression. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11500942     DOI: 10.1002/jcb.1192

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  27 in total

1.  Identification of USF2 as a key regulator of Runx2 expression in mouse pluripotent mesenchymal D1 cells.

Authors:  Chihuei Wang; Grace Lee; Wayne Hsu; Ching-Hua Yeh; Mei-Ling Ho; Gwo-Jaw Wang
Journal:  Mol Cell Biochem       Date:  2006-06-20       Impact factor: 3.396

2.  Dose-dependent effects of Runx2 on bone development.

Authors:  Shiqin Zhang; Zhousheng Xiao; Junming Luo; Nan He; Josh Mahlios; L Darryl Quarles
Journal:  J Bone Miner Res       Date:  2009-11       Impact factor: 6.741

3.  Co-stimulation of the bone-related Runx2 P1 promoter in mesenchymal cells by SP1 and ETS transcription factors at polymorphic purine-rich DNA sequences (Y-repeats).

Authors:  Ying Zhang; Mohammad Q Hassan; Rong-Lin Xie; John R Hawse; Thomas C Spelsberg; Martin Montecino; Janet L Stein; Jane B Lian; Andre J van Wijnen; Gary S Stein
Journal:  J Biol Chem       Date:  2008-11-18       Impact factor: 5.157

4.  Genomic occupancy of HLH, AP1 and Runx2 motifs within a nuclease sensitive site of the Runx2 gene.

Authors:  Hayk Hovhannisyan; Ying Zhang; Mohammad Q Hassan; Hai Wu; Carlotta Glackin; Jane B Lian; Janet L Stein; Martin Montecino; Gary S Stein; Andre J van Wijnen
Journal:  J Cell Physiol       Date:  2013-02       Impact factor: 6.384

5.  High bone resorption in adult aging transgenic mice overexpressing cbfa1/runx2 in cells of the osteoblastic lineage.

Authors:  Valérie Geoffroy; Michaela Kneissel; Brigitte Fournier; Alan Boyde; Patrick Matthias
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

6.  RUNX2 mutations in Chinese patients with cleidocranial dysplasia.

Authors:  Yalin Li; Wei Pan; Wanfeng Xu; Nan He; Xuewu Chen; Hong Liu; L Darryl Quarles; Honghao Zhou; Zhousheng Xiao
Journal:  Mutagenesis       Date:  2009-06-10       Impact factor: 3.000

7.  Kif3a deficiency reverses the skeletal abnormalities in Pkd1 deficient mice by restoring the balance between osteogenesis and adipogenesis.

Authors:  Ni Qiu; Li Cao; Valentin David; L Darryl Quarles; Zhousheng Xiao
Journal:  PLoS One       Date:  2010-12-02       Impact factor: 3.240

8.  Shox2 is required for chondrocyte proliferation and maturation in proximal limb skeleton.

Authors:  Ling Yu; Hongbing Liu; Mingquan Yan; Jing Yang; Fanxin Long; Ken Muneoka; YiPing Chen
Journal:  Dev Biol       Date:  2007-04-01       Impact factor: 3.582

Review 9.  Runx3 knockouts and stomach cancer.

Authors:  Ditsa Levanon; Ori Brenner; Florian Otto; Yoram Groner
Journal:  EMBO Rep       Date:  2003-06       Impact factor: 8.807

10.  General transcription factor IIA-gamma increases osteoblast-specific osteocalcin gene expression via activating transcription factor 4 and runt-related transcription factor 2.

Authors:  Shibing Yu; Yu Jiang; Deborah L Galson; Min Luo; Yumei Lai; Yi Lu; Hong-Jiao Ouyang; Jian Zhang; Guozhi Xiao
Journal:  J Biol Chem       Date:  2008-01-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.